The prevention of viral hepatitis.
Studies with heat-inactivated MS-2 serum have indicated that active immunization against hepatitis B infection can be achieved even though the virus has not been cultivated in tissue culture. The development of new biophysical, biochemical and immunological techniques has increased knowledge of the hepatitis B virus and its associated antigens. In the wake of these recent developments the accumulating evidence indicates that active immunization could be achieved by the use of purified hepatitis B surface antigen or by one of its polypeptides or glycolipids.
D006515:Hepatitis B virus; D006525:Hepatitis, Viral, Human / Q000517:prevention & control*; D006507:Hepatovirus; D006801:Humans; D007114:Immunization; D014611:Vaccination; D014765:Viral Vaccines; D005719:gamma-Globulins / Q000627:therapeutic use*
D014765:Viral Vaccines; D005719:gamma-Globulins